SAN JOSE, Calif., Aug. 17 /PRNewswire/ -- SI-BONE, Inc.

LOS ALTOS, Calif., Aug. 4 /PRNewswire/ -- InteKrin Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the development of products for diabetes, metabolism and obesity today announced it has completed the first close of a Series C venture financing for $18.25 million.

Dicerna Pharmaceuticals, Inc.

NEWARK, Calif., May 15 /PRNewswire/ -- Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that it has secured $49.5 million in Series D preferred stock financing.

DENVER, June 11 /PRNewswire/ -- ARCA Discovery Inc., a privately held biopharmaceutical company today announced that it has closed an $18 million Series B preferred stock financing. The proceeds from the financing will be used in part to file for U.S.